Abstract
Asthma is defined as a heterogeneous disease characterized by chronic airway inflammation. In recent years, the treatment strategy for this common disease has changed dramatically. Recently, guidelines for adolescents and younger children have given more attention to the use of inhaled corticosteroids whenever beta-agonists are used. This article reviews the changes in recent guidelines and the underlying evidence.